机译:BRAFV600E可能参与乳头状甲状腺癌基因表达的改变
Department of Genetics, Research Institute of Environmental Medicine, Nagoya University, 464-8601, Nagoya, Japan Department of Transplantation and Endocrine Surgery, Nagoya University Graduate School of Medicine, 466-8550, Nagoya, Japan;
Department of Genetics, Research Institute of Environmental Medicine, Nagoya University, 464-8601, Nagoya, Japan;
Department of Genetics, Research Institute of Environmental Medicine, Nagoya University, 464-8601, Nagoya, Japan Department of Transplantation and Endocrine Surgery, Nagoya University Graduate School of Medicine, 466-8550, Nagoya, Japan;
Department of Transplantation and Endocrine Surgery, Nagoya University Graduate School of Medicine, 466-8550, Nagoya, Japan;
Department of Transplantation and Endocrine Surgery, Nagoya University Graduate School of Medicine, 466-8550, Nagoya, Japan;
Department of Transplantation and Endocrine Surgery, Nagoya University Graduate School of Medicine, 466-8550, Nagoya, Japan;
Department of Genetics, Research Institute of Environmental Medicine, Nagoya University, 464-8601, Nagoya, Japan;
osteopontin; snail; epithelial to mesenchymal transition;
机译:BRAFV600E可能参与乳头状甲状腺癌基因表达的改变
机译:在甲状腺乳头状癌的小鼠模型中,BRAFV600E的产后表达不会诱导甲状腺癌
机译:DUSP4 / MKP2过表达与BRAF V600E sup>突变和甲状腺乳头状癌的侵袭行为有关
机译:深度学习平台中使用基因表达谱,药物基因组变异和量子图像处理预测甲状腺癌的治疗方法
机译:Med19改变了前列腺癌细胞中雄激素受体和基因表达的基因组占据,在低雄激素下促进生长
机译:乳头状甲状腺微癌的临床结果BRAFV600E的作用和分子途径:是惰性癌症还是乳头状甲状腺癌的早期阶段?
机译:在甲状腺乳头状癌中,BRAFV600E突变(而非RET / PTC重排)与甲状腺过氧化物酶和碘化钠共转运体基因的较低表达相关
机译:乳头状甲状腺癌组织中激酶表达和染色体重排:分子和显微镜水平的研究